financetom
Business
financetom
/
Business
/
USA Rare Earth Stock Jumps On Expansion: Rare Earths, Real Gains
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
USA Rare Earth Stock Jumps On Expansion: Rare Earths, Real Gains
Mar 11, 2026 1:06 AM

USA Rare Earth, Inc. ( USAR ) shares are moving higher on Tuesday after the company announced a strategic expansion into the European market. 

Through its subsidiary, Less Common Metals (LCM), USAR plans to develop a high-capacity metal and alloy production plant in Lacq, France, capable of producing 3,750 metric tons per annum.

USAR stock is climbing. See the chart and price action here. 

Strategic Support From The French Government

The project has received substantial backing from the French government through the C3IV program. The support package includes:

Direct Tax Credits: Up to 45% of all eligible equipment costs.

Real Estate Financing: Support totaling up to $152 million.

Workforce Development: Assistance with hiring initiatives and specialized training programs to cultivate local talent for the new facility.

Rare Earth Supply Chain

The new facility is designed to work in tandem with the existing industrial ecosystem in Lacq and will be co-located with Carester SAS's Caremag oxide processing facility, which is currently on track to begin operations in late 2026. 

By integrating these two operations, USAR is establishing a full-scale platform for rare-earth processing and metal production in Europe and strengthening the transatlantic supply chain.

“The development of an integrated rare earth processing and metal-making platform in France enhances USAR’s integrated rare earth value chain, to the benefit of the United States and our allies,” said Barbara Humpton, CEO of USAR. 

“We are proud to establish Europe’s first metal-making platform, which will accelerate the realization of a secure, sustainable transatlantic rare earth value chain," she added. 

USAR Price Action: USA Rare Earth ( USAR ) shares have gained more than 55% in January, buoyed by regulatory support for the critical minerals sector. USAR stock was up 6.95% at $18.92 on Tuesday, according to data from Benzinga Pro. 

Image: Shutterstock

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Citi taps tech chief Ryan to fix data management issues alongside Selva, memo shows
Citi taps tech chief Ryan to fix data management issues alongside Selva, memo shows
Sep 16, 2024
(Reuters) - Citigroup ( C/PN ) has tasked technology head Tim Ryan to work alongside Chief Operating Officer Anand Selva in fixing the bank's longstanding data management issues, according to a memo seen by Reuters on Monday. Ryan, who joined Citi in June from PwC's U.S. franchise, will jointly lead the data program along with Selva, who will continue to...
Lantronix Says CFO Jeremy Whitaker Resigned
Lantronix Says CFO Jeremy Whitaker Resigned
Sep 16, 2024
09:48 AM EDT, 09/16/2024 (MT Newswires) -- Lantronix ( LTRX ) said Monday that Chief Financial Officer Jeremy Whitaker resigned and left the company on Sept. 13. Whitaker accepted the CFO role at a private company, Lantronix ( LTRX ) said. Brent Stringham, who is Lantronix's ( LTRX ) controller, has been named interim CFO as the company searches for...
Lakeland Financial Insider Bought Shares Worth $292,680, According to a Recent SEC Filing
Lakeland Financial Insider Bought Shares Worth $292,680, According to a Recent SEC Filing
Sep 16, 2024
10:10 AM EDT, 09/16/2024 (MT Newswires) -- Stephanie R Leniski, Senior Vice President, on September 13, 2024, executed a purchase for 4,500 shares in Lakeland Financial ( LKFN ) for $292,680. Following the Form 4 filing with the SEC, Leniski has control over a total of 7,974 shares of the company, with 7,974 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/721994/000072199424000127/xslF345X05/wk-form4_1726495291.xml Price: 65.57,...
Ascendis Pharma Says Trial of Potential Dwarfism Drug Achieved Primary Endpoint
Ascendis Pharma Says Trial of Potential Dwarfism Drug Achieved Primary Endpoint
Sep 16, 2024
10:06 AM EDT, 09/16/2024 (MT Newswires) -- Ascendis Pharma ( ASND ) said Monday a trial of TransCon CNP, navepegritide, in children with achondroplasia achieved its primary endpoint of improving annualized growth velocity, or AGV, compared to a placebo. The company said the trial included 84 children with achondroplasia, a type of 'dwarfism,' aged between 2 years and 11 years....
Copyright 2023-2026 - www.financetom.com All Rights Reserved